Anxiety is a common condition which can manifest with symptoms of chest discomfort. Chest discomfort is one of the most common reasons to seek emergency medical care. We hypothesize that anxiety is highly prevalent, poorly diagnosed, and poorly treated in an acute care environment. We analyzed data from a prospective registry of chest pain patients with low to intermediate likelihood of acute coronary syndrome and coronary artery disease. Scores from the General Anxiety Disorder-7 questionnaire determined the prevalence of anxiety. Differences in presentation, evaluation, and 30 day outcomes were compared for subjects with and without severe anxiety. Of the 151 included subjects, severe anxiety was observed in 15%, moderate 14%, mild 30%, and 41% had no anxiety symptoms. Subjects with severe anxiety had similar baseline characteristics, cardiac risk factors, and symptoms to those without severe anxiety, except for the current use of tobacco 50.0% versus 18.6%, p=0.001). Anxiety was self-reported by 54.5% of subjects with severe anxiety and 27.3% were on antianxiety medications. Hospital admission (p=0.888) and repeat ED visits within 30 days (p=0.554) were not different between the two groups. Anxiety is common among patients seeking emergency evaluation of chest pain. Half of patients with severe anxiety were diagnosed and roughly one quarter were medically treated. Cardiac risk factors and symptoms are not different for patients with severe anxiety; these patients warrant a similar evaluation for heart disease as those patients without anxiety.
Introduction
Anxiety disorders are prevalent in the general population, affecting up to one in five patients in community samples 1 and higher in samples of patients referred for cardiac complaints. 2 These disorders are associated with poorer quality of life and higher utilization of health care resources. 3, 4, 5 Up to half of patients with generalized anxiety disorder report a history of chest pain symptoms and, for many patients, this distressing symptom prompts them to seek immediate medical attention at the nearest emergency department. 6 Chest pain complaints are also prevalent and are the principal reason for millions of emergency department (ED) visits in the United States annually. 7 Lacking a definitive test for anxiety related chest pain, ED doctors are obliged to evaluate each instance for lifethreatening conditions such as myocardial infarction and ischemia. These evaluations are time consuming and costly. Further, patients are frequently unsatisfied with the results as they are left wondering, "if not my heart, what is causing my symptoms?" Underrecognition and undertreatment of anxiety disorder could play a role in these patients seeking acute medical attention.
To investigate interactions between chest pain and anxiety, we evaluated data from patients evaluated at our institution's Chest Pain Evaluation Center (CPEC). The CPEC is a standalone section in our ED for extended observation and testing of chest pain patients with low to intermediate risk of acute coronary syndrome (ACS) and pretest likelihood of coronary artery disease (CAD). Patients in the CPEC are asked to participate in a prospective registry which includes several patient directed questionnaires, including a standardized assessment of anxiety symptoms. We hypothesize that anxiety is prevalent in this population and that anxiety is underdiagnosed and undertreated.
Materials and Methods
At our academic institution, patients presenting to the ED with an acute complaint of chest discomfort are evaluated for possible ACS. If initial laboratory testing and electrocardiogram (ECG) do not indicate ACS, patients are eligible for further care in the CPEC based on their age, symptoms, and CAD risk factors. The CPEC is a 8 bed unit physically located within our ED; further details on our CPEC and chest pain protocol have been previously described. 8 Further care for the patients includes serial laboratory testing and ECGs as well as testing for CAD, typically with either exercise treadmill testing or computed tomographic coronary angiography (CTCA). Patients in the CPEC are asked to participate in a prospective registry documenting their symptoms, medical history, standardized questionnaires, and outcomes. An analysis of anxiety symptoms was prespecified in the design of the registry.
Our institutional review board reviewed and approved this prospective registry which was conducted in accord with the Declaration of Helsinki. Written, informed consent was sought from all CPEC patients consecutively. Refusal to consent was the only exclusion criterion for the registry. After consent was given, registry data were collected on paper forms at the point of care. Data from those forms were recorded electronically in a custom database using REDcap software. 9 Data collected included demographics, symptoms, medical history, risk factors for CAD (age, gender, body mass index, hypertension, dyslipidemia, diabetes, tobacco use, history of stroke, and family history of coronary artery disease), comorbid conditions, and outcomes of the CPEC evaluation. Subjects were asked to describe three specific characteristics of their angina: the location, onset with exertion, and relief with rest. These responses were used to categorize angina using Diamond and Forrester's model: noncardiac (0 or 1 characteristics), atypical (2 characteristics), or typical (3 characteristics). 10 Each of these data fields as well as determinations about angina were made by the CPEC providers. These individuals are either nurse practitioners or physician assistants with specific training in both research methods and the evaluation/ management of chest pain. Monthly inservice meetings were held that served to review recent clinical encounters as well as discuss research progress with the principal investigator (DEW). Regular updates were discussed including review of enrollment and any difficulties with the study. Antianxiety medications broadly defined and based on patient self report, including benzodiazepines as well as neurotransmitter modulating drugs such as selective serotonin reuptake inhibitors. All subjects were contacted 30 days after their CPEC visit to ascertain any repeat ED visits, additional cardiovascular testing, or other cardiovascular events. Subjects were initially contact by phone; if they could not be reached, certified mail was sent to their last known address. Follow-up data was input directly into the REDcap database at the time of collection.
Subjects in the CPEC Registry are asked to complete several self-administered standardized questionnaires, including the GAD-7. 11 The GAD-7 is an instrument used to screen for generalized anxiety disorder and consists of seven questions, each rated on a zero to three scale, inquiring about anxiety related symptoms within the last 2 weeks. A score of 0-4 denotes no anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and over 15 severe anxiety. The GAD-7 has been used and validated in multiple populations; when comparing the GAD-7 to a structured psychiatric interview, area under the receiver-operator curve for generalized anxiety disorder is 0.91 and for any anxiety disorder is 0.86. 12, 13, 14 
Outcomes and Analysis
The outcomes for this investigation are to 1) establish the prevalence of anxiety in the CPEC registry and 2) make comparisons of presentation, evaluation, and outcomes for subjects with and without severe anxiety symptoms. Prevalence of anxiety was determined using GAD-7 scores for the entire CPEC Registry population. Patients with severe anxiety would be most likely to benefit from further evaluation and treatment of their psychiatric illness and were therefore selected as the focus of analysis. Comparisons were made between the subset of subjects with severe anxiety (GAD-7 score > 15) and the remainder of the subjects. Continuous variables were compared by the student's t-test. Categorical variables were compared using the chi square test. All statistical analyses were performed using SPSS version 21 (IBM, Armonk, NY). We followed the STROBE statement in the development and reporting of this investigation. 15 
Results
Of the subjects in the CPEC Registry, 151 were recruited from December 2011 through January 2013 and had complete data on their GAD-7 and 30 day followup. Distribution of anxiety scores based on the results of the GAD-7 questionnaire were 41% with no anxiety (score of 0-4), 30% with mild anxiety (score of 5-9), 14% with moderate anxiety (score of [10] [11] [12] [13] [14] , and 15% with severe anxiety (score ≥ 15). (Figure 1 ) Subjects were categorized as either severe anxiety (SA, n=22) or non-severe anxiety (NSA, n=129). Baseline characteristics are presented in Table 1 .
Baseline characteristics
Both groups were predominantly female, no difference in gender was observed between the two groups. (SA=63.6%, NSA=68.2%, p=0.67). The only cardiovascular risk factor difference between the groups was current tobacco use, more common in the SA group (50.0%) as compared to the NSA group (18.6%) (p=0.001). No differences were observed in prevalence of diabetes, hypertension, dyslipidemia, or family history of coronary artery disease.
Angina
Subjects were asked several questions about specific characteristics of their angina including the frequency of angina episodes in the week prior to ED evaluation and angina severity rating on a 10 point scale (1 being no pain at all, and 10 being the worst pain imaginable). (Table 2 ) Angina severity was significantly higher for the SA group (7.7 vs. 6.3 on 10 point scale, p=0.002) while angina episodes in the preceding week were non-significantly higher for the SA group (7.9 vs 3.7 episodes per week, p=0.267). The distribution of angina classifications was not different between the groups (p=0.269) and neither was the typical duration of angina symptoms (p=0.261). Numerically fewer patients in the SA group, however, had typical angina symptoms.
Anxiety
GAD-7 scores were used to classify subjects as having SA or NSA. Subjects were also asked if they had been clinically diagnosed with anxiety in the past. The prevalence of anxiety was higher in the SA group, however, only half of the subjects in the SA group were aware of their diagnosis (54.5% versus 18.6% in the NSA group, p<0.001); (Table 2) The use of medications to treat anxiety was higher in the SA group but only one quarter were receiving medications. (27.3% versus 7.0%, p=0.003), Subjects were asked to rate how worried they were about their chest pain. Of the SA group, 72.7% indicated they were very worried or extremely worried, compared to 34.7% of the NSA group (p<0.0001).
Evaluation and outcomes
Subjects with and without severe anxiety underwent a similar diagnostic testing while in the ED. (Table 3) In the NSA group, 57.4% underwent exercise treadmill stress testing versus 63.6% of the SA group (p=0.581), while 28.7% of the NSA group versus 22.7% of the SA group (p=0.565) underwent computed tomography coronary angiography. 5.8% of the NSA group versus 5% of the SA group (p=0.888) were admitted to the hospital for further evaluation. There was no statistical difference regarding 30 day follow up with a PCP or other doctor about chest pain (p=0.439), or 30 day recidivism to the ED with chest pain (p=0.554).
Discussion
While chest pain is a common primary reason for patients to seek acute care in an ED, the culprit diagnosis is heart disease in a minority of cases. This prospective evaluation of patients with chest pain and low risk of heart disease has established that anxiety is common, underdiagnosed, and undertreated.
We demonstrated our initial hypothesis that anxiety would be highly prevalent in our prospective registry. The possible causes for this observation, however, are multiple. We postulate that there is a true overrepresentation of anxiety disorder in the acute chest pain population. The observed prevalence of anxiety in our cohort is several fold higher than a general population (5% moderate, 1% severe), 13 but closer to that observed in another ED population (12.7% using another questionnaire). 16 This higher prevalence has also been reported in other populations of patients with chest pain and referred for chest pain evaluations. 2, 17 Within our cohort, however, subjects responded to a question about worry and their chest pain. SA group subjects were more likely to indicate a high degree of worry about their chest pain, but we cannot prove the causality of this relationship. Anxiety may provoke sensations of chest discomfort, however chest discomfort may also induce anxiety symptoms, particularly in those who already carry a diagnosis of anxiety. Anxiety is more common in patients with established heart disease 18 and has been linked to poorer outcomes for patients with demonstrated heart disease or ischemia. 19, 20 Given these confounders, the prospective clinical utility of our observation may be limited, especially during the initial evaluation of chest pain patients. While we observed a high prevalence of anxiety symptoms, the subjects with the most severe anxiety had essentially the same symptom and risk factor profile as the subjects without severe anxiety. Absence of any differences may be due to low power of our investigation for this sort of analysis. Anxiety may not be as useful as other signs and symptoms for distinguishing those with and without ACS, 21 making anxiety challenging to use to prospectively identify patients who could undergo a less extensive evaluation for heart disease. Once possible heart disease has been adequately evaluated, the clinical utility of diagnosing anxiety is more relevant. Screening for anxiety as part of a secondary assessment of chest pain would seem to be appropriate and has been demonstrated to be effective as part of a protocol to screen for psychiatric diseases, musculoskeletal disorders, and gastroesophageal reflux. 22 Screening for anxiety has been attempted with other instruments 23 and led to the development of additional questionnaires beyond the GAD-7. The Cardiac Anxiety Questionnaire, for example, sought to isolate cardiac anxiety from other forms of anxiety in hospitalized patients. 24 The Panic Screening Score is another instrument which has demonstrated modest accuracy in the ED setting. 25 These questionnaires have not been cross-validated with the GAD-7 or a reference standard, such as clinical psychiatric assessment, so it remains to be seen which might be the most relevant to the ED physician.
Our 30 day follow up did not demonstrate a significant difference between the SA and NSA groups with regard to return ED visits. We would presume that additional attention to establishing a firm diagnosis for a chest pain complaint would result in fewer return visits, however we cannot make such an assertion based on our data. Return visits were not a primary outcome for this investigation and will require further study.
Limitations
Our analysis is limited in having gathered data on anxiety and chest pain evaluation during the same encounter. Sample size leaves the investigation underpowered to determine if SA group patients have significantly risk of repeat ED visits. Selection bias is a possibility in our registry, however patients concerned about documentation of psychiatric disease would be less likely to participate and would then serve to underestimate anxiety. Proving a causal relationship between the two conditions is not possible with this investigation. As noted previously, interactions between anxiety, chest pain, and heart disease may confound the degree to which anxiety is a stand-alone diagnosis for subjects in this investigation.
Conclusions
In summary, anxiety is common in ED patients with chest pain with prevalence several fold higher than the general population. In the ED population, anxiety is markedly underdiagnosed and undertreated. CAD risk factors and symptoms were similar between patients with and without severe anxiety suggesting that a diagnosis of anxiety does not identify patients suitable for an abbreviated or accelerated heart disease evaluation. Subjects in this investigation completed a standardized questionnaire on anxiety symptoms to categorize them as having severe, moderate, mild, or no anxiety. This chart demonstrates the distribution of anxiety categories. 
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